The sentinel lymph node concept rests on a simple anatomical insight: when a tumour begins to spread, cancer cells do not scatter randomly through the lymphatic system. Instead, they travel first to one or a few nearby lymph nodes, the so-called sentinel nodes, which act as the initial filters on the drainage pathway. If surgeons can identify and remove precisely those nodes, pathologists can examine them closely for metastatic cells, and the wider lymphatic basin can be left intact when they are clean. This spares patients the morbidity of extensive lymph node dissection, which in the pelvis and para-aortic region can include lymphedema, lymphoceles, vascular injury, and prolonged recovery. Sentinel node biopsy has transformed the management of breast cancer and melanoma, and it is increasingly applied in endometrial and cervical cancer as well.

Ovarian cancer, however, has proven a harder target. The lymphatic drainage of the ovary is unusually complex, following the ovarian vessels upward along the infundibulopelvic ligament toward para-aortic nodes high in the retroperitoneum, while parallel pathways drain through the broad ligament to pelvic nodes along the iliac vessels. This dual drainage means that sentinel nodes in ovarian cancer can appear on both sides of the body and at considerable distance from the tumour, making reliable identification technically demanding. Moreover, most patients with ovarian cancer are diagnosed at advanced stages, when the disease has already spread beyond the ovary and full surgical staging with systematic lymphadenectomy is standard. It is in the smaller group of patients with apparently early-stage disease, where the distinction between stage I and stage III hinges on whether lymph nodes contain microscopic deposits, that a minimally invasive sentinel node approach would be most valuable.

The standard technique for sentinel node detection in ovarian cancer combines a radioactive tracer, technetium-99m radiocolloid, with a visual agent such as blue dye or indocyanine green, a fluorescent compound that glows under near-infrared light. The radiocolloid is injected near the tumour, drains to the sentinel nodes, and is located intraoperatively with a handheld gamma probe that clicks as it approaches the radioactive signal. Studies have shown this combination to be feasible, but each component carries practical drawbacks. Technetium-99m requires coordination with a nuclear medicine department, involves radiation exposure for patients and staff, and is subject to regulatory and logistical constraints that limit its availability in many hospitals, particularly in low-resource settings. Blue dye carries a small risk of anaphylaxis and can permanently tattoo the skin, while indocyanine green requires specialized near-infrared imaging equipment that works well through tissue only to a limited depth.

These limitations are especially acute in ovarian cancer surgery, which is typically performed by laparotomy, a large open abdominal incision, rather than by minimally invasive laparoscopy. Fluorescent tracers such as indocyanine green excel in laparoscopic procedures, where the camera system integrates the infrared imaging, but in an open surgical field the fluorescence can be difficult to visualize under standard operating room lighting, and the signal may be washed out by ambient light or obscured by tissue and blood. A tracer that could be detected with a simple handheld probe, without radiation and without dependence on optical conditions, would fit the open-surgery environment far more naturally. This is the gap that Magtrace is designed to fill.

Magtrace is a suspension of superparamagnetic iron oxide particles, micrometre-scale carriers loaded with even smaller iron oxide cores. Once injected into the tissue near the tumour, the particles are taken up by lymphatic vessels and carried to the regional lymph nodes, where they accumulate and impart a characteristic brown discoloration that surgeons can see directly. More importantly, the particles distort a local magnetic field in a way that a handheld device called the Sentimag probe can detect. The probe, which resembles a modified magnetometer, is passed over the surgical field and produces an audible and visual signal whose strength increases as it nears the magnetized tissue, allowing the surgeon to home in on the sentinel node much as a gamma probe tracks radioactivity. Because the magnetic signal is not attenuated by tissue in the way light is, and because it involves no ionizing radiation, the technique can in principle be used in any operating room without nuclear medicine support.

In the Maastricht study, the researchers injected both Magtrace and technetium-99m into the same anatomical structures, the ligamentum ovarii proprium, which connects the ovary to the uterus, and the infundibulopelvic ligament or its stumps, through which the ovarian vessels run toward the para-aortic region. Injecting both tracers at the same sites allowed a direct head-to-head comparison: after an interval of at least fifteen minutes, the surgical team located sentinel nodes using the Sentimag probe for the magnetic tracer and a gamma probe for the radiocolloid. The dual-tracer design is a common strategy in pilot studies of new tracers, because it lets investigators measure how often the new agent finds the same nodes as the established one, and whether it finds any nodes the standard technique misses.

The patient cohort illustrates the practical complexities of studying early ovarian cancer. Of the sixteen patients enrolled, ten actually received the tracer injections, nine during primary surgery for suspected ovarian cancer and one during secondary staging after a previous tumour resection had already confirmed the disease. Among the nine primary surgery patients, frozen-section analysis, the rapid microscopic examination of tissue performed while the patient is still on the operating table, revealed that six actually had benign or borderline tumours rather than invasive carcinoma, so the sentinel node procedure was not clinically relevant for them. That left three patients with confirmed epithelial ovarian cancer undergoing primary staging, and in all three the procedure succeeded, with at least one sentinel node identified using Magtrace. In the single patient who underwent mapping during secondary staging, the procedure was unsuccessful, a failure the authors note may relate to the altered anatomy and scar tissue left by the prior surgery, which can disrupt lymphatic drainage pathways.

The investigators conclude that Magtrace injection shows promise for sentinel node detection in epithelial ovarian cancer, while emphasizing that larger studies are needed to confirm its value. That caution is warranted. With only three successful primary staging cases, the study cannot establish detection rates, sensitivity, or false-negative rates, the metrics that ultimately determine whether a sentinel node technique is safe to rely on in clinical practice. The high proportion of benign frozen-section results also highlights a recurring challenge in this field: preoperative imaging often cannot reliably distinguish early ovarian cancer from benign masses, so trials of staging techniques must enroll generously and expect a substantial fraction of participants to fall outside the target diagnosis. The single failure in secondary staging likewise suggests that the technique’s role may be limited to primary surgery, at least initially.

Nevertheless, the study points toward a plausible future in which ovarian cancer staging becomes less burdensome. A magnetic tracer that works in open surgery, requires no radioactive material, and leaves a visible brown mark on the sentinel nodes could make sentinel node biopsy accessible to surgical teams worldwide who lack nuclear medicine infrastructure, and could simplify logistics for centres that do. Before that future arrives, the technique will need validation in larger prospective cohorts, ideally comparing Magtrace directly against the established radiocolloid and fluorescence combinations and following patients long enough to confirm that a negative sentinel node truly predicts the absence of regional metastases. For now, the Maastricht pilot offers an early but encouraging signal that the magnetic approach, so successful in breast cancer, may find a place in one of gynaecologic oncology’s most technically stubborn frontiers.

Subject of Research: Sentinel lymph node detection using the magnetic tracer Magtrace in early-stage epithelial ovarian cancer

Article Title: Magtrace as tracer for sentinel lymph node detection in early stage epithelial ovarian cancer: a pilot study

Article References: Laven, P., van der Pol, J. A. J., Slangen, B. F. M., Kruitwagen, R. F. P. M., & Lambrechts, S. (2026). Magtrace as tracer for sentinel lymph node detection in early stage epithelial ovarian cancer: a pilot study. Journal of Ovarian Research. https://doi.org/10.1186/s13048-026-02297-2

Image Credits: AI Generated

DOI: 10.1186/s13048-026-02297-2

Keywords: ovarian cancer, sentinel lymph node, Magtrace, magnetic tracer, superparamagnetic iron oxide, Sentimag, technetium-99m, indocyanine green, laparotomy, surgical staging, gynaecologic oncology, pilot study

Abdominal cocoon syndrome is a condition in which a fibrocollagenous membrane gradually encases loops of the small bowel, constricting them into a clustered mass that behaves like a mechanical bottleneck for digestion. The result is recurrent or complete small bowel obstruction, one of the most common surgical emergencies encountered worldwide. Obstruction of the small intestine is usually caused by postoperative adhesions, hernias, malignancy, or inflammatory bowel disease, but cocoon syndrome stands apart because it can strike patients who have never had abdominal surgery, a detail that makes clinicians far less likely to suspect it. The syndrome was first described in the medical literature in 1978, and its etiology remains poorly understood, though an inflammatory cascade is thought to stimulate fibroblast proliferation and collagen deposition, eventually producing the dense encapsulating layer that gives the disease its name.

The Tunisian patient’s history was notable precisely for its emptiness. He denied any prior abdominal surgery, peritoneal dialysis, abdominal trauma, appendicitis, gastrointestinal perforation, foreign-body ingestion, peptic ulcer disease, or inflammatory bowel disease. He took no chronic medications, including corticosteroids, nonsteroidal anti-inflammatory drugs, or opioids, and had no diabetes, hypertension, or autoimmune disorders. His family history was unremarkable for gastrointestinal disease or tuberculosis. On admission he appeared mildly dehydrated, with a distended, tympanic abdomen and diffuse tenderness but no signs of peritonitis. Laboratory tests showed mild leukocytosis of 13,000 cells per cubic millimeter, with otherwise normal electrolytes and inflammatory markers. Abdominal radiography revealed multiple air-fluid levels consistent with partial small bowel obstruction, prompting further imaging.

Contrast-enhanced computed tomography proved decisive. The scan demonstrated hydro-aeric distension of intestinal loops up to 57 millimeters in diameter, with progressive tapering in the right iliac fossa and moderate free fluid in the pelvis and left paracolic gutter. The characteristic finding, described in the literature as the cauliflower or cocoon sign, is a cluster of small bowel loops surrounded by a fibrotic sac, and the authors note that contrast-enhanced CT is considered the imaging modality of choice because of its ability to demonstrate this pattern. Even so, the diagnosis can remain elusive. Many cases in the published literature, including several in the review accompanying this report, were confirmed only during surgery, because the radiologic features are nonspecific and the syndrome itself is so rare that few radiologists or surgeons encounter it more than once in a career.

The patient was initially managed conservatively with nasogastric decompression, fluid resuscitation, and correction of electrolyte imbalance, a standard first-line approach for partial bowel obstruction. But his obstructive symptoms persisted after 48 hours, and the surgical team decided that exploratory laparotomy was indicated. Inside the abdomen, they found the small intestine encased within a dense, whitish fibrous membrane forming a cocoon-like sac. There was no mesenteric lymphadenopathy, no caseous nodules, and no purulent fluid, findings that helped argue against an infectious cause. The surgeons performed careful adhesiolysis, the deliberate freeing of adhesions, and total excision of the fibrotic capsule without bowel resection, because all loops were viable and regained peristalsis after release. Peritoneal fluid and membrane biopsies were sent for microbiological and histopathological evaluation, including acid-fast bacillus staining, culture, and adenosine deaminase assay, all of which came back negative for tuberculosis.

That tuberculosis work-up was not a formality. Secondary forms of abdominal cocoon syndrome are associated with peritoneal dialysis, tuberculosis, autoimmune diseases, and chronic infections, and the authors emphasize that clinicians evaluating recurrent small bowel obstruction should actively exclude tuberculous peritonitis, which can closely mimic the idiopathic form. They recommend a detailed tuberculosis history, chest imaging, and, when suspicion exists, targeted investigations such as ascitic or peritoneal fluid acid-fast bacillus smear, adenosine deaminase assay, culture, and molecular testing with CB-NAAT or GeneXpert. During surgery, representative peritoneal biopsy and fluid sampling for histopathology and microbiology are strongly recommended, because macroscopic appearance alone may not reliably exclude tuberculosis. In this case, histopathologic examination confirmed fibrocollagenous tissue without granulomatous inflammation, supporting an idiopathic diagnosis.

The postoperative course was swift. The patient was monitored for the return of bowel function, abdominal distension, and signs of infection, and oral intake resumed on postoperative day two after the passage of flatus. He received prophylactic antibiotics, ceftriaxone combined with metronidazole for 48 hours, along with analgesia, and was discharged on postoperative day four with normal bowel transit. At follow-up visits at two and six weeks he remained asymptomatic, and he expressed satisfaction with the outcome while providing written consent for publication of his clinical details and images. The authors report that early operative management of this syndrome generally results in excellent postoperative recovery and minimal recurrence, and their patient’s trajectory illustrates that point in practice.

To place the case in context, the team reviewed English-language literature on abdominal cocoon syndrome published between January 2015 and June 2024, searching PubMed and Google Scholar and including only single case reports and small case series with sufficient clinical detail. The synthesis, spanning cases from Pakistan, the United Kingdom, China, Greece, Egypt, Saudi Arabia, Iraq, Turkey, Kuwait, Morocco, India, Thailand, and Ethiopia, highlights that the syndrome predominantly affects young to middle-aged males from tropical and subtropical regions. Yet the collected cases also show the disease’s range of severity: some patients presented with straightforward obstruction, while others arrived with bowel perforation, internal fistulas, ischemic segments, or extensive small bowel necrosis. In a Thai series of three patients, one died, underscoring that delays in diagnosis can carry fatal consequences. Notably, the review also documents that idiopathic forms in middle-aged and older adults, like the Tunisian patient, are increasingly reported, even though the classic textbook portrait involves younger men.

Treatment remains an area of active debate. In early stages or in cases with intermittent symptoms, conservative management with bowel rest, hydration, nutritional support, and nasogastric decompression may be attempted. But when obstruction is complete or conservative measures fail, surgery is mandated, and the definitive procedure involves adhesiolysis and careful removal of the fibrous membrane encasing the intestine. There is growing interest in laparoscopic approaches, which offer reduced postoperative pain, faster recovery, and shorter hospital stays, and one case in the review achieved an excellent outcome with laparoscopic adhesiolysis. However, minimally invasive management is technically challenging because of dense adhesions and the risk of bowel injury, so case selection is crucial and conversion to open surgery may be required if safe dissection cannot be ensured. In the present case, the authors considered laparoscopy but deferred it because marked intestinal distension and dense adhesions on imaging made open laparotomy the safer approach. In patients with advanced liver cirrhosis or other comorbid conditions, perioperative morbidity is significantly heightened and approaches must be tailored accordingly.

The authors acknowledge the limits of the evidence base. No definitive pathophysiologic mechanism or molecular biomarker exists to distinguish idiopathic from secondary forms before surgery, CT sensitivity for early or partial disease is limited, and because the condition is so rare, treatment algorithms are largely derived from isolated case reports rather than comparative studies. Recurrence is exceptional but may occur when fibrotic tissue excision is incomplete or persistent inflammation promotes re-encapsulation, so the team advises structured follow-up with clinical evaluation at three and twelve months and abdominal imaging if symptoms return. Medical therapies aimed at modulating peritoneal fibrosis, including short courses of corticosteroids or tamoxifen, have been reported anecdotally but require validation, and the authors call for future multicenter registries to define optimal surveillance intervals and identify predictive factors for recurrence. Their central message for clinicians is straightforward: abdominal cocoon syndrome deserves a place on the differential diagnosis for any patient with recurrent or unexplained small bowel obstruction, especially those who have never undergone abdominal surgery, because timely recognition, careful bowel-preserving membrane excision, and structured postoperative monitoring can convert a potentially dangerous condition into one with an excellent outcome.

Subject of Research: Abdominal cocoon syndrome as a rare cause of small bowel obstruction

Article Title: Small bowel obstruction secondary to abdominal cocoon syndrome: Case report and review of the literature

Article References: Ben Ismail, I., Sghaier, M., Amari, R., Yaakoubi, J., Zenaidi, H., & Zoghlami, A. (2026). Small bowel obstruction secondary to abdominal cocoon syndrome: Case report and review of the literature. Heliyon, 12(15), Article e45437. https://doi.org/10.1016/j.heliyon.2026.e45437

Image Credits: AI Generated

DOI: 10.1016/j.heliyon.2026.e45437

Keywords: abdominal cocoon syndrome, sclerosing encapsulating peritonitis, small bowel obstruction, case report, computed tomography, adhesiolysis, fibrous membrane, tuberculosis, general surgery, Heliyon, idiopathic peritoneal sclerosis, laparotomy